Ibaraki, Japan

Haruhiko Kamada

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Haruhiko Kamada: Innovator in Antibody Drug Development

Introduction

Haruhiko Kamada is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of biomedical innovation, particularly in the development of antibody drugs. His work focuses on identifying target proteins that are crucial for drug discovery.

Latest Patents

Kamada holds a patent titled "Method for identifying drug-discovery target protein for development of antibody drug, and method for producing antibody against target protein." This patent describes a method for finding a protein present in minute amounts on a cell membrane, which is essential for producing an antibody against that protein. The process includes several steps: a labeling step using bis-iminobiotin and bis-biotin compounds, a degradation step to prepare a degradation product containing the labeled protein, an immobilization step to attach the labeled protein to a stationary phase via a streptavidin mutant, a cleavage step to release an analysis sample, and an analysis step to identify the labeled protein.

Career Highlights

Throughout his career, Haruhiko Kamada has worked with prominent organizations such as Mitsui Chemicals, Inc. and the National Institutes of Biomedical Innovation, Health and Nutrition. His experience in these institutions has allowed him to refine his expertise in the field of antibody drug development.

Collaborations

Kamada has collaborated with notable colleagues, including Tsuneji Suzuki and Yoshiyuki Totani. These partnerships have contributed to his innovative approaches in biomedical research.

Conclusion

Haruhiko Kamada's work in identifying drug-discovery target proteins and developing methods for producing antibodies has made a significant impact in the field of biomedical innovation. His contributions continue to influence the development of effective antibody drugs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…